Agnieszka K Witkiewicz

11PUBLICATIONS
109CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Apr 27, 2026
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond.

|Apr 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition.

|Apr 10, 2026
Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance.

Vishnu Kumarasamy, Jianxin Wang, Edwin Yau

|Nov 19, 2025
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma.

Kennedy S Humphrey, Katherine J Crawford, Bharani Muppavarapu

|Feb 20, 2025
Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma.

Katherine J Crawford, Kennedy S Humphrey, Eduardo Cortes

Pageof 2

Frequent Collaborators

11 joint publications

Erik S Knudsen

5 joint publications

Jianxin Wang

4 joint publications

Ethan V Abel

3 joint publications

Vishnu Kumarasamy